Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lori Claussen"'
Autor:
Syd Staggs, Natalie J. Nokoff, Stacey Whiteside, Robert Franklin, Lev Levett, Rachel Sewell, Ariel Porto, Daniel Reirden, Dwight Christopher Poppy, Abby Simon, Lori Claussen, Cindy L. Buchanan
Publikováno v:
Transgender health. 7(5)
In this mixed-methods quality improvement project, we implemented and evaluated sexual orientation and gender identity (SOGI) form rollout in the electronic medical record. Families in our gender diversity program completed a baseline survey in 2017
Autor:
Gira S. Morchi, Joseph Kay, Kak-Chen Chan, D. Dunbar Ivy, Mark C. Duster, RN Lori Claussen Bsn
Publikováno v:
Congenital Heart Disease. 4:107-111
Objective. The purpose of this study was to investigate the effect of sildenafil in patients with failing Fontan physiology. Design. A retrospective chart review was performed to compare history and available data in patients with Fontan circulations
Autor:
Po-Feng Lee, Robin Shandas, K. Chen Chan, Lori Claussen, Kendall S. Hunter, K. Scott Kirby, Craig Lanning, D. Dunbar Ivy
Publikováno v:
American Heart Journal. 155:166-174
Background Pulmonary vascular resistance (PVR) is the current standard for evaluating reactivity in children with pulmonary arterial hypertension (PAH). However, PVR measures only the mean component of right ventricular afterload and neglects pulsati
Autor:
Robin Shandas, D. Dunbar Ivy, Martin L. Dunn, Kendall S. Hunter, S. James Chen, Lori Claussen, Yanhang Zhang, Craig Lanning
Publikováno v:
Journal of Biomechanical Engineering. 129:193-201
We applied a statistical mechanics based microstructural model of pulmonary artery mechanics, developed from our previous studies of rats with pulmonary arterial hypertension (PAH), to patient-specific clinical studies of children with PAH. Our previ
Autor:
Delphine Yung, Adele Morganti, Erika B. Rosenzweig, Aimee Doran, D. Dunbar Ivy, Ngoc Nguyen, Steven H. Abman, Lori Claussen, Robyn J. Barst, Allison C. Widlitz
Publikováno v:
Journal of the American College of Cardiology. 46(4):697-704
ObjectivesThis study investigated the long-term outcome of children with pulmonary arterial hypertension (PAH) treated with bosentan therapy, with or without concomitant prostanoid therapy.BackgroundBosentan, an oral endothelin ETA/ETBreceptor antago
Publikováno v:
The American Journal of Cardiology. 99:696-698
Intravenous epoprostenol was the first agent approved by the United States Food and Drug Administration for the management of pulmonary arterial hypertension (PAH). However, epoprostenol therapy carries the risks of a short half-life (6 minutes) and
Autor:
Lori Claussen, Maurice Beghetti, Donna K. Parker, Kelly J. Smith, George B. Mallory, D. Dunbar Ivy, Yuk M. Law, Daniela Brady, Steven H. Abman, Aimee Doran, Robyn J. Barst
Publikováno v:
Journal of the American College of Cardiology, Vol. 51, No 2 (2008) pp. 161-9
Objectives This study investigated the short- and long-term outcome of children with pulmonary arterial hypertension (PAH) treated with inhaled iloprost. Background Inhaled iloprost has been approved for the treatment of adults with PAH, but little i
Autor:
Lori Claussen, Aimee Doran, John R. Whitworth, Ronald J. Sokol, Michael R. Narkewicz, Sarah Mengshol, Adria A. Condino, D. Dunbar Ivy, Judith A. O'Connor
Objectives To investigate the clinical presentation, manifestations, and response to therapy of portopulmonary hypertension (PPHTN) in pediatric patients. Study design This study was a retrospective chart review describing the evaluation and course o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79f8dda9cd719f29a1d5df01f1f899c
https://europepmc.org/articles/PMC3326402/
https://europepmc.org/articles/PMC3326402/
In 7 of 8 children with idiopathic pulmonary arterial hypertension treated with intravenous epoprostenol for > 1 year, concomitant use of bosentan allowed a reduction of epoprostenol and decreased its associated side effects without deterioration of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265b30d4e958aecf71a0d502217e771d
https://europepmc.org/articles/PMC3138203/
https://europepmc.org/articles/PMC3138203/
Autor:
D. Dunbar Ivy, Karrie L. Dyer, Linda B. Pauliks, Scott K. Kirby, Lori Claussen, Lilliam M. Valdes-Cruz, Robin Shandas
Publikováno v:
Journal of the American College of Cardiology. 43(5)